Suda T, Tomori N, Yajima F, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K
J Clin Invest. 1985 Nov;76(5):2026-9. doi: 10.1172/JCI112204.
Plasma immunoreactive corticotropin-releasing factor (I-CRF) levels were determined by using a human CRF radioimmunoassay and an immunoaffinity procedure. The basal plasma I-CRF level in normal subjects was 6 +/- 0.5 pg/ml (mean +/- SD). We found that most plasma I-CRF levels were affected by stress, negative feedback, and circadian rhythm. Basal I-CRF levels were high in patients with Addison's disease, Nelson's syndrome, hypopituitarism stemming from pituitary macroadenoma, and CRF- and adrenocorticotropic hormone-producing tumors. A very low, but significant, amount of I-CRF was detected (1-3 pg/ml) in patients with Cushing's syndrome, in corticosteroid-treated patients, and in a patient with hypothalamic hypopituitarism. These results suggest that a major component of plasma I-CRF is of hypothalamic origin, however, other extrahypothalamic tissues cannot be ruled out as a minor source of plasma I-CRF.
采用人促肾上腺皮质激素释放因子(CRF)放射免疫分析法和免疫亲和法测定血浆免疫反应性促肾上腺皮质激素释放因子(I-CRF)水平。正常受试者的基础血浆I-CRF水平为6±0.5 pg/ml(均值±标准差)。我们发现大多数血浆I-CRF水平受应激、负反馈和昼夜节律影响。艾迪生病、尼尔森综合征、垂体大腺瘤所致垂体功能减退以及产生CRF和促肾上腺皮质激素的肿瘤患者的基础I-CRF水平较高。在库欣综合征患者、接受皮质类固醇治疗的患者以及一名下丘脑性垂体功能减退患者中检测到非常低但显著的I-CRF量(1-3 pg/ml)。这些结果表明,血浆I-CRF的主要成分起源于下丘脑,然而,不能排除其他下丘脑外组织作为血浆I-CRF次要来源的可能性。